Published in Curr Opin Virol on September 01, 2011
Influenza A virus hemagglutinin trimerization completes monomer folding and antigenicity. J Virol (2013) 1.56
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc Natl Acad Sci U S A (2014) 1.49
Influenza viruses: breaking all the rules. MBio (2013) 1.14
Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe (2013) 1.13
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Rep (2015) 0.99
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol (2014) 0.97
The antigenic evolution of influenza: drift or thrift? Philos Trans R Soc Lond B Biol Sci (2013) 0.90
Antiviral B cell and T cell immunity in the lungs. Nat Immunol (2015) 0.86
Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol (2014) 0.85
Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful. Arch Immunol Ther Exp (Warsz) (2013) 0.83
Development of a universal CTL-based vaccine for influenza. Bioengineered (2013) 0.78
Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza. Philos Trans R Soc Lond B Biol Sci (2015) 0.77
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity. Microbiol Mol Biol Rev (2016) 0.75
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine (2007) 9.96
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol (1993) 6.26
T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol (2006) 6.23
Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science (2010) 5.13
Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature (1981) 5.00
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest (2010) 4.62
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34
Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med (2007) 3.63
Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A (2006) 3.25
Influenza virus assembly and budding. Virology (2011) 2.90
Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A (2003) 2.54
Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol (2010) 2.53
The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol (2001) 2.52
Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol (1986) 2.52
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Expression of influenza A virus internal antigens on the surface of infected P815 cells. J Immunol (1981) 2.36
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med (1983) 2.27
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol (2008) 2.10
Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice. J Exp Med (1955) 2.05
Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect (2008) 1.88
Antibody-mediated modulation of immune responses. Immunol Rev (2010) 1.84
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A (2010) 1.81
Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol (2011) 1.74
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol (1987) 1.70
Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. Arch Virol (2000) 1.61
Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog (2010) 1.57
Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. J Immunol (1982) 1.46
Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol (2011) 1.35
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature (1977) 1.30
Cross-protective immunity to influenza A viruses. Expert Rev Vaccines (2010) 1.28
Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One (2011) 1.24
Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol (1986) 1.14
Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. J Virol (1993) 1.12
The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis (2010) 1.09
Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J Infect Dis (1994) 1.03
Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS One (2010) 1.03
Evolution and hierarchy of influenza viruses. Arch Environ Health (1970) 1.00
Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine (2011) 0.94
Hybrid antibody-mediated lysis of virus-infected cells. Eur J Immunol (1987) 0.84
Prevention and treatment of lethal influenza A virus bronchopneumonia in mice by monoclonal antibody against haemagglutinin stem region. Acta Virol (1997) 0.82
Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry. Biologicals (2010) 0.81
Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin. Proc Natl Acad Sci U S A (2011) 0.79
Sequence variation in the haemagglutinin-neuraminidase gene of human parainfluenza virus type 3 isolates in the UK. Epidemiol Infect (1995) 0.78
DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol (2011) 1.42
Greasing the SCIDs for universal flu antibodies. Cell Host Microbe (2013) 0.75
Amsterdamming DRiPs. Mol Immunol (2012) 0.75